Search research articles
Contact Us
Filters
Showing results (241-250 of 271) with videos related to
Page
of 28
Sort By:
European Urology
|
December 22, 2018
Pelvic Complications After Prostate Cancer Radiation Therapy and Their Management: An International Collaborative Narrative Review
Rano Matta, Christopher R Chapple, Margit Fisch, et al.
BJU International
|
July 4, 2017
Comparative assessment of the efficacy of onabotulinumtoxinA and oral therapies (anticholinergics and mirabegron) for overactive bladder: a systematic review and network meta-analysis
Marcus J Drake, Victor W Nitti, David A Ginsberg, et al.
European Urology Focus
|
October 19, 2019
Multicriteria Decision Analysis Applied to the Clinical Use of Pharmacotherapy for Overactive Bladder Symptom Complex
Christopher R Chapple, Emma Mironska, Adrian Wagg, et al.
European Urology
|
March 16, 2015
The underactive bladder: a new clinical concept?
Christopher R Chapple, Nadir I Osman, Lori Birder, et al.
European Urology Focus
|
January 10, 2021
Corrigendum re "Multicriteria Decision Analysis Applied to the Clinical Use of Pharmacotherapy for Overactive Bladder Symptom Complex" [Eur Urol Focus 2020;6:522-30]
Christopher R Chapple, Emma Mironska, Adrian Wagg, et al.
Neurourology and Urodynamics
|
December 12, 2025
Are There Potential New Therapeutic Avenues for Treating Idiopathic Nocturia? ICI-RS 2025
Qi-Xiang Song, Sanjay Sinha, Bahareh Vahabi, et al.
European Urology
|
March 23, 2011
Defining a patient-reported outcome measure for urethral stricture surgery
Matthew J Jackson, John Sciberras, Altaf Mangera, et al.
Neurourology and Urodynamics
|
January 15, 2016
What was hot at the ICS meeting 2015
Alison J Hainsworth, Paula Igualada-Martinez, Marianne Koch, et al.
Blood Pressure Monitoring
|
March 27, 2018
A strategy utilizing ambulatory monitoring and home and clinic blood pressure measurements to optimize the safety evaluation of noncardiovascular drugs with potential for hemodynamic effects: a report from the SYNERGY trial
Michael A Weber, Christopher R Chapple, Christian Gratzke, et al.
International Urogynecology Journal
|
March 9, 2013
A phase II dose-ranging study of mirabegron in patients with overactive bladder
Christopher R Chapple, Vladimir Dvorak, Pjotr Radziszewski, et al.
Page
of 28
Search research articles
Search
Showing results (241-250 of 271) with videos related to
Sort By:
Page
of 28
European Urology
|
December 22, 2018
Pelvic Complications After Prostate Cancer Radiation Therapy and Their Management: An International Collaborative Narrative Review
Rano Matta, Christopher R Chapple, Margit Fisch, et al.
BJU International
|
July 4, 2017
Comparative assessment of the efficacy of onabotulinumtoxinA and oral therapies (anticholinergics and mirabegron) for overactive bladder: a systematic review and network meta-analysis
Marcus J Drake, Victor W Nitti, David A Ginsberg, et al.
European Urology Focus
|
October 19, 2019
Multicriteria Decision Analysis Applied to the Clinical Use of Pharmacotherapy for Overactive Bladder Symptom Complex
Christopher R Chapple, Emma Mironska, Adrian Wagg, et al.
European Urology
|
March 16, 2015
The underactive bladder: a new clinical concept?
Christopher R Chapple, Nadir I Osman, Lori Birder, et al.
European Urology Focus
|
January 10, 2021
Corrigendum re "Multicriteria Decision Analysis Applied to the Clinical Use of Pharmacotherapy for Overactive Bladder Symptom Complex" [Eur Urol Focus 2020;6:522-30]
Christopher R Chapple, Emma Mironska, Adrian Wagg, et al.
Neurourology and Urodynamics
|
December 12, 2025
Are There Potential New Therapeutic Avenues for Treating Idiopathic Nocturia? ICI-RS 2025
Qi-Xiang Song, Sanjay Sinha, Bahareh Vahabi, et al.
European Urology
|
March 23, 2011
Defining a patient-reported outcome measure for urethral stricture surgery
Matthew J Jackson, John Sciberras, Altaf Mangera, et al.
Neurourology and Urodynamics
|
January 15, 2016
What was hot at the ICS meeting 2015
Alison J Hainsworth, Paula Igualada-Martinez, Marianne Koch, et al.
Blood Pressure Monitoring
|
March 27, 2018
A strategy utilizing ambulatory monitoring and home and clinic blood pressure measurements to optimize the safety evaluation of noncardiovascular drugs with potential for hemodynamic effects: a report from the SYNERGY trial
Michael A Weber, Christopher R Chapple, Christian Gratzke, et al.
International Urogynecology Journal
|
March 9, 2013
A phase II dose-ranging study of mirabegron in patients with overactive bladder
Christopher R Chapple, Vladimir Dvorak, Pjotr Radziszewski, et al.
Page
of 28